ClearVue Technologies has boosted its capital raising to $6.25 million, with significant board participation and revised loan terms, while its Gen 3 Vision Glass secures crucial EN 1279-5 certification.
- Capital raise increased to $6.25 million via placement and fully underwritten SPP
- Board and management commit $0.4 million, including loan-funded shares with new terms
- Gen 3 Vision Glass passes EN 1279-5 certification for double glazed units
- Joint Lead Managers’ fees revised with management fees, retainers, and options
- Post-raise shares to total approximately 361.6 million with nearly 73.7 million attaching options
Capital Raise Surpasses Initial Target with Strong Board Backing
ClearVue Technologies Limited (ASX:CPV) has expanded its capital raising to $6.25 million, exceeding the initial $5 million target announced just a day earlier. The raise comprises $5.25 million from a placement and a fully underwritten $1 million Share Purchase Plan (SPP), reflecting robust demand from investors. Notably, the company’s Board and management are injecting $0.4 million themselves, signalling confidence in ClearVue’s growth trajectory.
The Chair, Theresa Smits, is set to subscribe for $86,250 worth of shares, pending shareholder approval. Additionally, directors will acquire shares through a loan funded share plan, with an aggregate loan pool of $327,500. This plan, established pre-IPO, has been updated with more commercial terms: a two-year loan term and an interest rate pegged to the current Australian Government bond rate of 4.81%, replacing the original interest-free, ten-year term structure. These changes align director incentives with shareholder interests while maintaining prudent governance.
Revised Capital Structure and Manager Fees
Following the raise, ClearVue’s total shares on issue will climb to approximately 361.6 million, including 42.8 million placement shares, 8.7 million SPP shares, and nearly 2.85 million loan funded shares for directors. Attaching options on a one-for-one basis will bring the total options outstanding to nearly 73.7 million, including 19.4 million options allocated to the Joint Lead Managers.
The company also revised the fee structure for Alpine Capital and SP Corporate Advisory, the Joint Lead Managers. They will now receive a 6% management and selling fee on gross proceeds, a $10,000 one-off cash fee, and a monthly retainer of $12,000 for 12 months, contingent on raising a minimum of $6 million. Subject to shareholder approval, the managers will also be granted options linked to the placement and SPP shares, with a fallback cash equivalent arrangement if approval is not secured within eight weeks.
Gen 3 Vision Glass Achieves Key European Certification
In tandem with the capital raise, ClearVue announced that its Gen 3 Vision Glass has passed the EN 1279-5:2018 certification. This European standard governs the long-term sealing performance of insulating glass units (IGUs) used in construction, including hermetic integrity and resistance to moisture ingress.
ClearVue’s unique patent-applied-for design allows power cables to pass through the seal of a double glazed unit without compromising its primary seal, a critical feature for building-integrated photovoltaics (BIPV). The certification validates the product’s compatibility with industry-standard aluminium spacers, widely used in commercial curtain wall systems globally. This milestone reduces risk for builders and façade engineers and supports ClearVue’s push to integrate advanced low emissivity coatings for enhanced thermal performance.
Strategic Implications and Next Steps
The capital raise and certification milestone come at a pivotal time for ClearVue as it seeks to commercialise its solar-integrated building materials on a larger scale. The board’s material participation and revised loan terms underscore management’s commitment to the company’s near-term growth and execution strategy. Meanwhile, the Gen 3 Vision Glass certification addresses a key technical hurdle, potentially accelerating adoption in commercial construction markets.
Investors will be watching for shareholder approvals on the board’s participation and the Joint Lead Managers’ options, as well as the final SPP offer price, which could affect the ultimate number of shares issued. The company’s ability to leverage these funds into product development, certification, and market expansion will be critical to watch in the coming quarters.
Bottom Line?
ClearVue’s boosted capital raise backed by board investment and a critical product certification sets a foundation for scaling its solar façade technology, but shareholder approvals and execution remain key hurdles.
Questions in the middle?
- Will shareholder approvals for board participation and lead manager options proceed smoothly?
- How will ClearVue deploy the new capital to accelerate commercialisation and international expansion?
- Can the Gen 3 Vision Glass certification translate into meaningful contract wins in key construction markets?